Time | Haemoglobin level (reference range 11.5–14.5 g/dL) | Platelet count (reference range 150–400 × 109/L) | C3 level (reference range 0.80–1.60 g/L) | Protein excretion in first-morning urine dipstick (reference range < 30 mg/dL) |
---|---|---|---|---|
At time of diagnosis and eculizumab initiation | 5.9 | 23 | 0.55 | > 400 |
1 month after diagnosis | 9 | 169 | 0.91 | 100 |
6 months on eculizumab every 2 weeks | 11.8 | 543 | NA | 100 |
1 month after increasing the eculizumab interval to every 3 weeks | 12.2 | 494 | 0.78 | 300 |
4 months after increasing the eculizumab interval to every 3 weeks | 11.1 | 462 | NA | 300 |
1 month after resuming eculizumab every 2 weeks | 12.2 | 491 | NA | 100 |
4 months after resuming eculizumab every 2 weeks | 11 | 641 | NA | 100 |